Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Senti Biosciences (SNTI) Current Leases (2021 - 2025)

Senti Biosciences (SNTI) has 5 years of Current Leases data on record, last reported at $5.2 million in Q3 2025.

  • For Q3 2025, Current Leases rose 14.87% year-over-year to $5.2 million; the TTM value through Sep 2025 reached $5.2 million, up 14.87%, while the annual FY2024 figure was $4.6 million, 15.28% up from the prior year.
  • Current Leases reached $5.2 million in Q3 2025 per SNTI's latest filing, up from $5.0 million in the prior quarter.
  • Across five years, Current Leases topped out at $5.2 million in Q3 2025 and bottomed at $95000.0 in Q2 2023.
  • Average Current Leases over 5 years is $3.1 million, with a median of $3.3 million recorded in 2023.
  • Peak YoY movement for Current Leases: tumbled 95.14% in 2024, then surged 4711.0% in 2025.
  • A 5-year view of Current Leases shows it stood at $1.7 million in 2021, then grew by 10.27% to $1.9 million in 2022, then soared by 109.73% to $4.0 million in 2023, then rose by 15.28% to $4.6 million in 2024, then grew by 10.89% to $5.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Leases were $5.2 million in Q3 2025, $5.0 million in Q2 2025, and $4.8 million in Q1 2025.